Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Targeting cyclooxygenase by indomethacin decelerates progression of acute lymphoblastic leukemia in a xenograft model.

Autor: Richartz N; Department of Molecular Medicine, Institute of Basic Medicine, University of Oslo, Oslo, Norway., Duthil E; Department of Molecular Medicine, Institute of Basic Medicine, University of Oslo, Oslo, Norway., Ford A; Centre for Evolution & Cancer, The Institute of Cancer Research, London, United Kingdom., Naderi EH; Department of Molecular Medicine, Institute of Basic Medicine, University of Oslo, Oslo, Norway.; Section of Head and Neck Oncology, Department of Oncology, Oslo University Hospital, Oslo, Norway., Bhagwat S; Department of Molecular Medicine, Institute of Basic Medicine, University of Oslo, Oslo, Norway., Gilljam KM; Department of Molecular Medicine, Institute of Basic Medicine, University of Oslo, Oslo, Norway., Burman MM; Department of Hematology and Oncology, Division of Pediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway; and., Ruud E; Department of Hematology and Oncology, Division of Pediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway; and.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Blomhoff HK; Department of Molecular Medicine, Institute of Basic Medicine, University of Oslo, Oslo, Norway., Skah S; Department of Molecular Medicine, Institute of Basic Medicine, University of Oslo, Oslo, Norway.

Publikováno v: Blood advances [Blood Adv] 2019 Nov 12; Vol. 3 (21), pp. 3181-3190.